• Fighting Fanconi anemia...Improving the Lives of Children
  • 1
 
The primary mission of the Kendall And Taylor Atkinson Foundation (KATA) is to support scientific and medical research to find effective treatments and a cure for Fanconi anemia (FA), and its related side effects.

FA is a genetic blood disease that causes bone marrow failure and is associated with a high rate of leukemia and various other forms of cancer.

Due to the high incidence of cancer in FA patients, the disease has captured the attention of researchers worldwide.  Discovering a link between defective FA genes and certain cancers such as ovarian, pancreatic, prostate and breast cancer in the non-FA population has led many top researchers to believe that finding a cure for the disease may be a key to beating cancer itself.

KATA has funded over $1 million in Fanconi anemia research, including research into the causes, treatment and prevention of cancers particularly harmful to FA patients. Click here for a list of specific research funded.

 

Children Living WIth Disease, Disability and Poverty

With the commitment to reflect the lives and hearts of Kendall and Taylor, KATA also provides a limited amount of funding for projects that improve the lives of children living with the challenges of disease, disability and poverty. Since 2006, KATA has provided over $240,000 in funding for these secondary projects*.  Click here for a list of specific projects funded.

 

How You Have Helped

Recognizing that the disease carries a significant risk of various cancers, FA has generated tremendous interest in the scientific world, many researchers speculating that it may hold the key to a cure for cancer.

As the genetic basis of Fanconi anemia continues to be deciphered and FA's role in the DNA repair pathway clarified, your donations are also having an impact on the lives of millions in the general population.

 

Research efforts into Fanconi anemia have demonstrated that a rare genetic disorder can provide a vital key to understanding the basic biological process of cancer itself. The importance of these efforts to the advancement of medical science cannot be overstated.
- Lee Hartwell, PhD, President and Director, Fred Hutchinson Cancer Research Center, Seattle, WA. Winner, Nobel Prize, 2001.

 

*KATA is governed by a nine member Board of Directors that is committed to minimizing costs in order to maximize the impact of money raised.  Since its formation in 2006, KATA has kept its combined administrative and fundraising costs at less than 11%.